Genetic component to Parkinson’s disease discovered

NewsGuard 100/100 Score

Dr Ananya Mandal, MD

Parkinson’s disease, a severely degenerative disease of the brain leading to tremors, muscle rigidity and finally immobility was until the 1990’s believed to be due to environmental factors, lifestyle and a person’s age. However, now scientists have discovered five more genes that influence its development. Scientists reveal that around 5% of people with Parkinson’s inherit genes which increase the risk of developing the disease. The study was published this Wednesday in The Lancet and has been hailed as “an exciting step forward” towards understanding the disease. PD affects about 120,000 people in Britain, or one in 500.

With this study a total 11 genes have been identified to be linked to PD. The study - the largest of its kind in the world - mapped and compared the DNA of 12,000 people with Parkinson’s and more than 21,000 without it. It noted that the fifth of people with the highest number of genetic “risk variants” were 2.5 times more likely to develop PD than those with the lowest number. Authors write, “This study provides evidence that common genetic variation plays an important part in the cause of Parkinson’s disease… We have confirmed a strong genetic component to Parkinson’s disease, which, until recently, was thought to be completely caused by environmental factors.”

One of the co-authors, Prof Nick Wood, of the University College London Institute for Neurology said, “Discovering five new genes is an exciting step forward and will help us understand more about why and how nerve cells die…These findings significantly add to the knowledge base of the increasingly complex picture of the molecules that can cause Parkinson’s.”

Dr Kieran Breen, director of research and development at the charity Parkinson’s UK, which helped fund the study, said, “In 2004 Parkinson’s UK funded researchers helped uncover changes in the LRRK2 gene…This is one of the most important genes involved in Parkinson’s and studies are looking at whether this may be a target for new drugs…In the same way, we hope that the results from this new study will lead to similar advances and help us to move closer towards better treatments, or even a cure for Parkinson’s.”

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2020, April 03). Genetic component to Parkinson’s disease discovered. News-Medical. Retrieved on May 07, 2024 from https://www.news-medical.net/news/20110203/Genetic-component-to-Parkinsons-disease-discovered.aspx.

  • MLA

    Mandal, Ananya. "Genetic component to Parkinson’s disease discovered". News-Medical. 07 May 2024. <https://www.news-medical.net/news/20110203/Genetic-component-to-Parkinsons-disease-discovered.aspx>.

  • Chicago

    Mandal, Ananya. "Genetic component to Parkinson’s disease discovered". News-Medical. https://www.news-medical.net/news/20110203/Genetic-component-to-Parkinsons-disease-discovered.aspx. (accessed May 07, 2024).

  • Harvard

    Mandal, Ananya. 2020. Genetic component to Parkinson’s disease discovered. News-Medical, viewed 07 May 2024, https://www.news-medical.net/news/20110203/Genetic-component-to-Parkinsons-disease-discovered.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New biomarkers identified for predicting psychosis risk in 22q11.2 deletion syndrome